Medical Marijuana Laws Affect Medicare Part D Spending

This article originally appeared here.
Share this content:
Medical Marijuana Laws Affect Medicare Part D Spending
Medical Marijuana Laws Affect Medicare Part D Spending

FRIDAY, July 8, 2016 (HealthDay News) -- Legalization of medical marijuana and its associated availability have affected prescribing patterns and spending in Medicare Part D, according to a study published online July 6 in Health Affairs.

Ashley C. Bradford, and W. David Bradford, Ph.D., both from the University of Georgia in Atlanta, used data on all prescriptions filled by Medicare Part D enrollees from 2010 to 2013 to examine whether medical marijuana is being used clinically to any significant degree.

The researchers found that once a medical marijuana law was implemented, there was a significant decrease in the use of prescription drugs for which marijuana could serve as a clinical alternative. When states implemented medical marijuana laws, the national overall reductions in Medicare program and enrollee spending were estimated to be $165.2 million per year in 2013.

"The availability of medical marijuana has a significant effect on prescribing patterns and spending in Medicare Part D," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Onabotulinum Toxin-A Can Safely Improve Sleep Bruxism

Onabotulinum Toxin-A Can Safely Improve Sleep Bruxism

Improved clinical global impression and change in visual analog scale, pain at 4 to 8 weeks post therapy

Professionals Disagree About Asking Patients About Sexuality

Professionals Disagree About Asking Patients About Sexuality

Article offers opposing views about recommendation in England to ask patients about sexual orientation

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

Greater improvement in symptom scores versus placebo, but clinical relevance unclear

is free, fast, and customized just for you!

Already a member?

Sign In Now »